Assignee

GRITGEN THERAPEUTICS LTD

CN·1 granted patent·1 pending application·0 citations·filing 2020–2022

Technology mixA61K2 A61P2 C07K2 C12N2 C12Y1

Top patents by PatentIndex Score

2 records

0148US2024335564A1Isolated nucleic acid molecule and use thereofGRITGEN THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
0241US12544461B2Isolated nucleic acid molecule and application thereofGRITGEN THERAPEUTICS LTD·Filed 2020·Granted Feb 10, 2026·0 cites·17 claims

Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →